155 related articles for article (PubMed ID: 35383919)
1. Stereotactic body radiotherapy of adrenal metastases-A dose-finding study.
Buergy D; Würschmidt F; Gkika E; Hörner-Rieber J; Knippen S; Gerum S; Balermpas P; Henkenberens C; Voglhuber T; Kornhuber C; Barczyk S; Röper B; Rashid A; Blanck O; Wittig A; Herold HU; Brunner TB; Sweeney RA; Kahl KH; Ciernik IF; Ottinger A; Izaguirre V; Putz F; König L; Hoffmann M; Combs SE; Guckenberger M; Boda-Heggemann J
Int J Cancer; 2022 Aug; 151(3):412-421. PubMed ID: 35383919
[TBL] [Abstract][Full Text] [Related]
2. On the pitfalls of PTV in lung SBRT using type-B dose engine: an analysis of PTV and worst case scenario concepts for treatment plan optimization.
Leung RWK; Chan MKH; Chiang CL; Wong M; Blanck O
Radiat Oncol; 2020 May; 15(1):130. PubMed ID: 32471457
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis.
Buergy D; Würschmidt F; Gkika E; Hörner-Rieber J; Knippen S; Gerum S; Balermpas P; Henkenberens C; Voglhuber T; Kornhuber C; Barczyk S; Röper B; Rashid A; Blanck O; Wittig A; Herold HU; Brunner TB; Klement RJ; Kahl KH; Ciernik IF; Ottinger A; Izaguirre V; Putz F; König L; Hoffmann M; Combs SE; Guckenberger M; Boda-Heggemann J
Int J Cancer; 2021 Jul; 149(2):358-370. PubMed ID: 33682927
[TBL] [Abstract][Full Text] [Related]
4. Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance.
Kestin L; Grills I; Guckenberger M; Belderbos J; Hope AJ; Werner-Wasik M; Sonke JJ; Bissonnette JP; Xiao Y; Yan D;
Radiother Oncol; 2014 Mar; 110(3):499-504. PubMed ID: 24630539
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy for adrenal oligometastasis in lung cancer patients.
Arcidiacono F; Aristei C; Marchionni A; Italiani M; Fulcheri CPL; Saldi S; Casale M; Ingrosso G; Anselmo P; Maranzano E
Br J Radiol; 2020 Nov; 93(1115):20200645. PubMed ID: 32822540
[TBL] [Abstract][Full Text] [Related]
7. Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases.
Andratschke N; Parys A; Stadtfeld S; Wurster S; Huttenlocher S; Imhoff D; Yildirim M; Rades D; Rödel CM; Dunst J; Hildebrandt G; Blanck O
Radiat Oncol; 2016 May; 11():74. PubMed ID: 27236333
[TBL] [Abstract][Full Text] [Related]
8. Harmonization of dose prescription for lung stereotactic radiotherapy.
Beldjoudi G; Bosson F; Bernard V; Puel LM; Martel-Lafay I; Ayadi M; Tanguy R
Phys Imaging Radiat Oncol; 2022 Oct; 24():65-70. PubMed ID: 36213173
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary oligometastases treated by stereotactic body radiation therapy (SBRT): a single institution's experience.
Chai G; Yin Y; Zhou X; Hu Q; Lv B; Li Z; Shi M; Zhao L
Transl Lung Cancer Res; 2020 Aug; 9(4):1496-1506. PubMed ID: 32953521
[TBL] [Abstract][Full Text] [Related]
10. Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation Therapy.
Zhao L; Zhou S; Balter P; Shen C; Gomez DR; Welsh JD; Lin SH; Chang JY
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1226-35. PubMed ID: 27209498
[TBL] [Abstract][Full Text] [Related]
11. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.
Yamada Y; Katsoulakis E; Laufer I; Lovelock M; Barzilai O; McLaughlin LA; Zhang Z; Schmitt AM; Higginson DS; Lis E; Zelefsky MJ; Mechalakos J; Bilsky MH
Neurosurg Focus; 2017 Jan; 42(1):E6. PubMed ID: 28041329
[TBL] [Abstract][Full Text] [Related]
12. Significant correlation between gross tumor volume (GTV) D98% and local control in multifraction stereotactic radiotherapy (MF-SRT) for unresected brain metastases.
Dupic G; Brun L; Molnar I; Leyrat B; Chassin V; Moreau J; Dedieu V; Khalil T; Verrelle P; Lapeyre M; Biau J
Radiother Oncol; 2021 Jan; 154():260-268. PubMed ID: 33245944
[TBL] [Abstract][Full Text] [Related]
13. Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: Recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91.
de Jong EEC; Guckenberger M; Andratschke N; Dieckmann K; Hoogeman MS; Milder M; Møller DS; Nyeng TB; Tanadini-Lang S; Lartigau E; Lacornerie T; Senan S; Verbakel W; Verellen D; De Kerf G; Hurkmans C
Radiother Oncol; 2020 Jan; 142():217-223. PubMed ID: 31767472
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Stahl JM; Ross R; Harder EM; Mancini BR; Soulos PR; Finkelstein SE; Shafman TD; Dosoretz AP; Evans SB; Husain ZA; Yu JB; Gross CP; Decker RH
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1011-1020. PubMed ID: 27869080
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Body Radiation Therapy for Pulmonary Metastasis from Colorectal Adenocarcinoma: Biologically Effective Dose 150 Gy is Preferred for Tumour Control.
Lee TH; Kang HC; Chie EK; Kim HJ; Wu HG; Lee JH; Kim KS
Clin Oncol (R Coll Radiol); 2023 Jun; 35(6):e384-e394. PubMed ID: 37003842
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study.
Baydoun A; Chen H; Poon I; Badellino S; Dagan R; Erler D; Foote MC; Louie AV; Redmond KJ; Ricardi U; Sahgal A; Biswas T
Clin Transl Radiat Oncol; 2022 Mar; 33():159-164. PubMed ID: 35243027
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysis.
Franzese C; Nicosia L; Facondo G; Lo Faro L; Cuccia F; Vullo G; Osti MF; Alongi F; Scorsetti M
Clin Exp Metastasis; 2021 Dec; 38(6):511-518. PubMed ID: 34651241
[TBL] [Abstract][Full Text] [Related]
18. Robotic stereotactic body radiotherapy for the management of adrenal gland metastases: a bi-institutional analysis.
Ehret F; Kaul D; Kufeld M; Endt CV; Budach V; Senger C; Fürweger C; Haidenberger A; Muacevic A
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1095-1101. PubMed ID: 35290521
[TBL] [Abstract][Full Text] [Related]
19. Clinical Results of Mean GTV Dose Optimized Robotic-Guided Stereotactic Body Radiation Therapy for Lung Tumors.
Baumann R; Chan MKH; Pyschny F; Stera S; Malzkuhn B; Wurster S; Huttenlocher S; Szücs M; Imhoff D; Keller C; Balermpas P; Rades D; Rödel C; Dunst J; Hildebrandt G; Blanck O
Front Oncol; 2018; 8():171. PubMed ID: 29868486
[TBL] [Abstract][Full Text] [Related]
20. Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer.
Xu B; Zhao X; Chen D; Zhao W; Wang X; Ding C; Yuan Z; Zhang H
BMC Cancer; 2023 Jan; 23(1):73. PubMed ID: 36681809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
